Neutral with upside potential. Oscar Health (
OSCR) is at $20.41, down 0.34% daily but up 36.43% monthly, as shown in the finance card above. X posts highlight strong bullish sentiment, with a weekly wedge breakout and high volume fueling optimism for a move toward $25-$30. Fundamentals are solid, with 42% Q1 2025 revenue growth, $1.2B net cash, and 660% EPS growth projected for 2025. However, volatility (13% weekly) and a downgrade to Market Perform by Raymond James (price target cut to $18) signal caution. Support is at $19.50-$20; resistance is at $21.36-$23.79. A breakout above $21.36 could target $25, but earnings concerns and a high valuation (255% premium per Morningstar) cap near-term upside
OSCR) is at $20.41, down 0.34% daily but up 36.43% monthly, as shown in the finance card above. X posts highlight strong bullish sentiment, with a weekly wedge breakout and high volume fueling optimism for a move toward $25-$30. Fundamentals are solid, with 42% Q1 2025 revenue growth, $1.2B net cash, and 660% EPS growth projected for 2025. However, volatility (13% weekly) and a downgrade to Market Perform by Raymond James (price target cut to $18) signal caution. Support is at $19.50-$20; resistance is at $21.36-$23.79. A breakout above $21.36 could target $25, but earnings concerns and a high valuation (255% premium per Morningstar) cap near-term upside
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。